Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply

被引：0
|
作者：
You, Benoit [1 ,2 ,3 ]
Bolze, Pierre-Adrien [1 ,2 ,4 ]
Golfier, Francois [1 ,2 ,4 ]
机构：
[1] Ctr Reference Malad Trophoblast, Lyon, France
[2] Univ Claude Bernard Lyon 1, Univ Lyon, EMR UCBL, HCL 3738, Lyon, France
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Inst Cancerol, Med Oncol,IC HCL,CITOHL, Lyon, France
[4] Hosp Civils Lyon, Serv Chirurg Gynecol & Oncol, Obstet, Ctr Hosp Lyon Sud, Pierre Benite, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 36期
关键词：
PEMBROLIZUMAB; PHASE-3;
D O I：
10.1200/JCO.20.02911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4350 / +
页数：3
相关论文
共 50 条
  • [1] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4349 - +
  • [2] Actinomycin-D for methotrexate-resistant low-risk gestational trophoblastic neoplasia (GTN)
    Lurain, J.
    Schink, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S67 - S67
  • [3] Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia
    Maesta, Izildinha
    Nitecki, Roni
    Freitas Desmarais, Cecilia Canedo
    Horowitz, Neil S.
    Goldstein, Donald P.
    Elias, Kevin M.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 372 - 378
  • [4] Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
    Mitra Mohit
    Zahra Sarraf
    Gelavizh Sheikhi
    Minoo Robati
    Amir Vasheghani-Farahani
    Archives of Gynecology and Obstetrics, 2009, 280 : 775 - 780
  • [5] Outcome of low-risk gestational trophoblastic neoplasia (GTN) treated with methotrexate
    Ahmeed, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 202 - 202
  • [6] Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
    Mohit, Mitra
    Sarraf, Zahra
    Sheikhi, Gelavizh
    Robati, Minoo
    Vasheghani-Farahani, Amir
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (05) : 775 - 780
  • [7] OUTCOME OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN) TREATED WITH METHOTREXATE
    Alobaid, A.
    Ahmeed, S.
    Saleh, R.
    Mattar, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [8] Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia
    Anfinan, N. M.
    Al Khatieb, M. T.
    Sait, H. K.
    Sait, M. K.
    Baghlaf, O. A.
    Mousa, A. A.
    Sait, K. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (02) : 227 - 232
  • [9] Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia
    Yarandi, Fariba
    Eftekhar, Zahra
    Shojaei, Hadi
    Kanani, Soheyla
    Sharifi, Ali
    Hanjani, Parviz
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (01) : 33 - 37
  • [10] ABCB1 and SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia
    Srisuttayasathien, Manasawee
    Areepium, Nutthada
    Lertkhachonsuk, Ruangsak
    PERSONALIZED MEDICINE, 2021, 18 (02) : 107 - 114
12345